CRNX - Crinetics Pharmaceuticals, Inc.
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$85.83
DETAILS
HIGH:
$105.00
LOW:
$67.00
MEDIAN:
$85.50
CONSENSUS:
$85.83
UPSIDE:
133.23%
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | ||||||||||
| Revenue | 7.7 | 1.0 | 4.0 | 4.7 | 1.1 | 0.1 | 1.2 | 2.4 | 2.0 | 0.6 |
| Cost of Revenue | 1.1 | 0 | 0 | 0 | 0 | 57.0 | 1.1 | 24.5 | 9.2 | 5.1 |
| Gross Profit | 6.6 | 1.0 | 4.0 | 4.7 | 1.1 | (56.9) | 0.1 | (22.1) | (7.2) | (4.5) |
| Operating Expenses | ||||||||||
| R&D Expenses | 332.1 | 240.2 | 168.5 | 130.2 | 84.3 | 57.6 | 41.5 | 24.5 | 9.2 | 5.1 |
| SG&A Expenses | 191.3 | 99.7 | 58.1 | 42.4 | 24.5 | 18.0 | 13.5 | 6.7 | 1.9 | 1.5 |
| Other Expenses | 0 | 0 | 0 | 0 | 0 | (57.6) | (1.2) | 1.6 | (0.0) | (0.0) |
| Operating Expenses | 523.4 | 339.9 | 226.6 | 172.6 | 108.8 | 18.0 | 53.8 | 28.7 | 9.1 | 6.0 |
| Operating Income | ||||||||||
| Operating Income | (516.8) | (338.9) | (222.6) | (167.9) | (107.7) | (75.0) | (53.8) | (28.7) | (9.1) | (6.0) |
| Interest Expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.0 | 0.0 |
| Interest Income | 52.0 | 41.4 | 13.4 | 4.3 | 0.2 | 1.0 | 3.5 | 1.7 | 0.0 | 0.0 |
| Profitability | ||||||||||
| EBITDA | (512.9) | (336.1) | (221.5) | (166.9) | (106.8) | (74.0) | (49.3) | (28.2) | (9.0) | (6.0) |
| EBIT | (516.8) | (338.9) | (222.6) | (167.9) | (107.7) | (75.0) | (53.8) | (27.1) | (9.1) | (6.0) |
| Income Before Tax | (465.1) | (298.4) | (214.5) | (163.9) | (107.6) | (73.8) | (50.4) | (27.1) | (9.2) | (6.0) |
| Income Tax Expense | 0.2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | (0.0) | 0.0 |
| Net Income | (465.3) | (298.4) | (214.5) | (163.9) | (107.6) | (73.8) | (49.5) | (27.1) | (9.2) | (6.0) |
| Per Share Data | ||||||||||
| EPS (Basic) | -4.95 | -3.69 | -3.69 | -3.15 | -2.80 | -2.42 | -2.05 | -2.23 | -0.66 | -0.43 |
| EPS (Diluted) | -4.95 | -3.69 | -3.69 | -3.15 | -2.80 | -2.42 | -2.05 | -2.23 | -0.66 | -0.43 |
| Shares Outstanding | 94.1 | 80.8 | 58.1 | 52.0 | 38.4 | 30.4 | 24.2 | 12.1 | 13.9 | 13.9 |
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Current Assets | ||||||||||
| Cash & Cash Equivalents | 101.5 | 264.5 | 54.9 | 32.7 | 200.7 | 93.1 | 40.3 | 45.0 | 14.2 | 12.2 |
| Short-Term Investments | 926.4 | 1,089.5 | 503.7 | 301.8 | 133.0 | 77.8 | 78.1 | 118.9 | 0 | 0 |
| Net Receivables | 0.6 | 8.5 | 9.4 | 2.4 | 2.0 | 1.8 | 1.4 | 0 | 0.7 | 0.1 |
| Inventory | 2.0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.1 | 0.1 |
| Other Current Assets | 17.8 | 1.7 | 1.6 | 2.5 | 0 | 1.0 | 1.1 | 0 | 0 | 0.0 |
| Total Current Assets | 1,048.3 | 1,375.4 | 574.2 | 345.2 | 344.7 | 177.5 | 123.3 | 166.7 | 15.2 | 12.4 |
| Non-Current Assets | ||||||||||
| Property, Plant & Equipment | 54.8 | 55.6 | 57.4 | 5.0 | 4.7 | 5.4 | 6.5 | 4.2 | 0.4 | 0.2 |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long-Term Investments | 0.8 | 0.8 | 1.8 | 2.0 | 1.0 | 0 | 0.5 | 0.5 | 0 | 0 |
| Other Non-Current Assets | 22.3 | 2.8 | 2.0 | 0.0 | 0.6 | 0.5 | 0.1 | 0 | 0.0 | 0.0 |
| Total Non-Current Assets | 87.2 | 59.2 | 61.2 | 7.0 | 6.3 | 6.0 | 7.0 | 4.7 | 0.4 | 0.2 |
| Total Assets | 1,135.5 | 1,434.6 | 635.4 | 352.2 | 351.0 | 183.4 | 130.4 | 171.4 | 15.6 | 12.6 |
| Current Liabilities | ||||||||||
| Account Payables | 22.6 | 5.9 | 6.5 | 6.9 | 3.4 | 3.5 | 2.7 | 1.5 | 0.4 | 0.3 |
| Short-Term Debt | 6.5 | 0 | 4.2 | 1.1 | 0 | 0 | 0.7 | 0 | 0 | 0.0 |
| Deferred Revenue | 1.2 | 2.2 | 2.1 | 2.2 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 19.2 | 0.0 | 16.6 | 8.5 | 7.5 | 4.9 | 2.8 | 0.6 | 0 | 0 |
| Total Current Liabilities | 85.1 | 59.7 | 43.9 | 27.7 | 16.0 | 10.5 | 8.3 | 7.9 | 0.9 | 0.9 |
| Non-Current Liabilities | ||||||||||
| Long-Term Debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.2 |
| Deferred Tax Liabilities | 9.2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 3.2 | 0.8 | 0 | 0 | 0.0 | 0.0 | 0.0 | 3.3 | 29.7 | 17.8 |
| Total Non-Current Liabilities | 58.3 | 50.1 | 52.3 | 8.1 | 3.1 | 4.0 | 4.9 | 3.3 | 29.7 | 17.9 |
| Total Liabilities | 143.4 | 109.8 | 96.2 | 35.8 | 19.1 | 14.5 | 13.2 | 11.2 | 30.6 | 18.8 |
| Stockholders' Equity | ||||||||||
| Common Stock | 2,407.8 | 2,276.0 | 1,191.8 | 759.4 | 607.6 | 336.5 | 210.8 | 0.0 | 0.0 | 0.0 |
| Retained Earnings | (1,417.4) | (952.1) | (653.7) | (439.2) | (275.3) | (167.6) | (93.8) | (43.4) | (16.3) | (7.1) |
| Accumulated Other Comprehensive Income | 1.8 | 1.0 | 1.0 | (3.9) | (0.4) | 0.0 | 0.1 | 0.1 | (0.3) | (0.2) |
| Total Stockholders' Equity | 992.1 | 1,324.8 | 539.1 | 316.3 | 331.9 | 168.9 | 117.1 | (43.4) | (15.0) | (6.2) |
| Total Liabilities & Equity | 1,135.5 | 1,434.6 | 635.4 | 352.2 | 351.0 | 183.4 | 130.4 | (32.2) | 15.6 | 12.6 |
| Debt Metrics | ||||||||||
| Total Debt | 48.5 | 51.7 | 51.7 | 3.1 | 3.1 | 4.0 | 5.6 | 0 | 0 | 0.2 |
| Net Debt | (53.0) | (212.8) | (3.2) | (29.6) | (197.6) | (89.1) | (34.8) | (45.0) | (14.2) | (11.9) |
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||||
| Net Income | (465.3) | (298.4) | (214.5) | (163.9) | (107.6) | (73.8) | (50.4) | (27.1) | (9.2) | (6.0) |
| Depreciation & Amortization | 3.9 | 2.8 | 1.1 | 1.0 | 0.9 | 0.9 | 0.9 | 0.5 | 0.1 | 0.1 |
| Stock-Based Compensation | 91.0 | 69.4 | 40.9 | 28.3 | 17.4 | 10.4 | 6.3 | 2.3 | 0.3 | 0.3 |
| Change in Working Capital | 4.8 | 11.6 | 8.0 | 18.6 | 1.1 | 0.4 | (2.1) | 5.3 | (0.7) | 0.2 |
| Other Non-Cash Items | (12.4) | (11.4) | (1.9) | 0.8 | (0.7) | 0.3 | 0.2 | (0.4) | 0.5 | 0.2 |
| Operating Cash Flow | (377.9) | (226.0) | (166.3) | (115.2) | (88.6) | (62.0) | (46.4) | (19.5) | (9.5) | (5.5) |
| Investing Activities | ||||||||||
| Capital Expenditure | (5.8) | (3.8) | (4.7) | (1.7) | (0.4) | (0.2) | (0.5) | (1.1) | (0.3) | (0.2) |
| Acquisitions | 0 | 0 | 0 | 0 | 0.4 | (0.2) | (1.2) | 0 | 0 | 0 |
| Purchases of Investments | (1,019.9) | (1,146.8) | (532.9) | (329.8) | (125.4) | (135.6) | (108.1) | (118.4) | 0 | 0 |
| Sales/Maturities of Investments | 1,184.1 | 575.8 | 337.1 | 157.5 | 69.4 | 136.0 | 150.3 | 0 | 0 | 0 |
| Other Investing Activities | 15.4 | 0 | 0 | 0 | (0.4) | 0.2 | 1.2 | (118.4) | 0 | 0 |
| Investing Cash Flow | 173.9 | (574.8) | (200.4) | (174.0) | (56.5) | 0.2 | 41.7 | (119.5) | (0.3) | (0.2) |
| Financing Activities | ||||||||||
| Net Debt Issuance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | (0.2) | (0.0) |
| Stock Repurchased | 0 | 0 | 0 | 0 | 0 | 0 | (0.1) | 0 | 0 | (0.0) |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | 0 | 40.4 | 19.9 | 4.7 | 3.1 | 0.3 | 0.1 | 0.5 | 0.1 | (0.0) |
| Financing Cash Flow | 40.6 | 1,010.4 | 388.9 | 122.0 | 252.7 | 114.6 | 0.1 | 170.2 | 11.8 | (0.1) |
| Cash Position | ||||||||||
| Net Change in Cash | (163.5) | 209.6 | 22.2 | (167.2) | 107.6 | 52.8 | (4.6) | 31.3 | 2.0 | (5.7) |
| Cash at Beginning | 265.8 | 56.2 | 34.0 | 201.2 | 93.6 | 40.8 | 45.5 | 14.2 | 12.2 | 17.9 |
| Cash at End | 102.3 | 265.8 | 56.2 | 34.0 | 201.2 | 93.6 | 40.8 | 45.5 | 14.2 | 12.2 |
| Free Cash Flow | (383.7) | (229.8) | (171.0) | (116.9) | (89.0) | (62.2) | (46.9) | (20.5) | (9.8) | (5.7) |
| Key Metrics | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||||
| Revenue | 7.7 | 1.0 | 4.0 | 4.7 | 1.1 | 0.1 | 1.2 | 2.4 | 2.0 | 0.6 |
| Gross Profit | 6.6 | 1.0 | 4.0 | 4.7 | 1.1 | (56.9) | 0.1 | (22.1) | (7.2) | (4.5) |
| Operating Income | (516.8) | (338.9) | (222.6) | (167.9) | (107.7) | (75.0) | (53.8) | (28.7) | (9.1) | (6.0) |
| Net Income | (465.3) | (298.4) | (214.5) | (163.9) | (107.6) | (73.8) | (49.5) | (27.1) | (9.2) | (6.0) |
| EPS (Diluted) | -4.95 | -3.69 | -3.69 | -3.15 | -2.80 | -2.42 | -2.05 | -2.23 | -0.66 | -0.43 |
| Balance Sheet | ||||||||||
| Cash & Equivalents | 101.5 | 264.5 | 54.9 | 32.7 | 200.7 | 93.1 | 40.3 | 45.0 | 14.2 | 12.2 |
| Total Assets | 1,135.5 | 1,434.6 | 635.4 | 352.2 | 351.0 | 183.4 | 130.4 | 171.4 | 15.6 | 12.6 |
| Total Debt | 48.5 | 51.7 | 51.7 | 3.1 | 3.1 | 4.0 | 5.6 | 0 | 0 | 0.2 |
| Stockholders' Equity | 992.1 | 1,324.8 | 539.1 | 316.3 | 331.9 | 168.9 | 117.1 | (43.4) | (15.0) | (6.2) |
| Cash Flow | ||||||||||
| Operating Cash Flow | (377.9) | (226.0) | (166.3) | (115.2) | (88.6) | (62.0) | (46.4) | (19.5) | (9.5) | (5.5) |
| Capital Expenditure | (5.8) | (3.8) | (4.7) | (1.7) | (0.4) | (0.2) | (0.5) | (1.1) | (0.3) | (0.2) |
| Free Cash Flow | (383.7) | (229.8) | (171.0) | (116.9) | (89.0) | (62.2) | (46.9) | (20.5) | (9.8) | (5.7) |